TRANSFORM National UK Trial of Prostate Cancer Screening
Dr. Rhian Gabe outlines the UK’s TRANSFORM trial, evaluating PSA thresholds, MRI, and polygenic risk scores to inform modern prostate cancer screening policy.
Read More
Select Page
Rhian Gabe, MSE, PhD, is a Professor of Biostatistics and Clinical Trials at Wolfson Institute of Population Health in London, England. Dr. Gabe’s research interests include trials and cancer screening, prevention and early detection. She is the lead statistician for studies evaluating interventions for prostate cancer detection and the implementation of low dose CT screening delivered through mobile vans in the community for people at high risk of lung cancer.
Dr. Gabe earned her Bachelor’s degree in Mathematics from the University of Liverpool in England. She then earned her Master’s in Epidemiology from the University of Cambridge in England. Dr. Gabe earned her PhD, using statistical methods to evaluate breast cancer screening using mammography, from Queen Mary, University of London in England.
Dr. Gabe previously served in the MRC Clinical Trials Unit, London and York Trials Unit gaining experience of analysing, designing and leading trials. She has worked on national and international studies of imaging for detection of prostate cancer, preventive interventions for HIV and leishmaniasis, smoking cessation in the context of TB management, treatments for testis cancer, brain tumours, pulmonary infection and venous leg ulcers.
Rhian Gabe, MSE, PhD | Oct 2025
Dr. Rhian Gabe outlines the UK’s TRANSFORM trial, evaluating PSA thresholds, MRI, and polygenic risk scores to inform modern prostate cancer screening policy.
Read More